CompaniesPotentia Pharmaceuticals

Potentia Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

27

By Phase

PHASE1: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
Today
NCT00473928
Hover over trial bars to see details

Recent Trials

NCT00473928Lead Sponsor
Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)
PHASE1Completed
27 participants
Started: May 31, 2007 · Completed: Feb 28, 2010
Related Companies
Apellis Pharmaceuticals
acquired